Scott WilliamsNuclear MedicineTumor ImagingNeotect (Tc99-m-Depreotide) (P-829)Scott WilliamsApr 2, 2002Neotect (Tc99-m-Depreotide) (P-829) Clinical Chemistry and pharmacology Patient Instructions Imaging Protocol Interpretation Indications for the exam Dosimetry Complications/Side Effects HAMA Formation (Immunogenicity) Latest in Tumor ImagingTumor > Therapy > Xofigo and other Prostate AgentsAugust 16, 2017Tumor > Therapy > Xofigo and PSMA therapiesJanuary 26, 2015Sponsored"Join Us"September 3, 2025Tumor > Therapy > MicrospheresJanuary 31, 2008Related StoriesNuclear MedicineProstascint (111In-Capromab Pendetide) (CYT-356)Nuclear MedicineTc-99m-Arcitumomab (CEA-Scan)Tumor ImagingThallium Tumor Imaging:Sponsor Content"Join Us"